Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 2, 2012, Pages 306-315

  Ambruso, Daniel R ^a,b,c   Ellison, Michael A ^a   Thurman, Gail W ^a   Leto, Thomas L ^d  

^a Bonfils Blood Center   (United States)

^b Children's Hospital Colorado   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

K562 cell; NADPH oxidase; Neutrophil; Peroxiredoxin 6

Indexed keywords

OXIDOREDUCTASE; PEROXIREDOXIN 6; PROTEIN P47; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA;

ADULT; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; WESTERN BLOTTING;

CELL MEMBRANE; HUMANS; K562 CELLS; NADPH OXIDASE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIREDOXIN VI; PROTEIN ISOFORMS; PROTEIN SUBUNITS; RNA, SMALL INTERFERING; TRANSGENES;

EID: 84855770662     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.11.014     Document Type: Article

References (50)

1. Klebanoff S.J., Clark R.A. The Neutrophil: Functions and Clinical Disorders 1978, Elsevier, Amsterdam.
2. Leto T.L. The respiratory burst oxidase. Inflammation Basic Principles and Clinical Correlates 1999, 769-787. Lippincott, Williams and Watkins, Philadelphia. third ed. J.I. Gallin, R. Snyderman (Eds.).
3. Unkeless J.C. Function and heterogeneity of human Fc receptors for immunoglobulin G. J. Clin. Invest. 1989, 83:355-361.
4. Huizenga T.W., Roos R., von dem Borne A.E. Neutrophil Fc-gamma receptors: a two way bridge in the immune system. Blood 1990, 75:1211-1214.
5. Berger M., O'Shea J., Cross A.S., Folks T.M., Chused T.M., Brown E.J., Frank M.M. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J. Clin. Invest. 1984, 74:1566-1571.
6. Ambruso D.R., Johnston R.B. Chronic granulomatous disease of childhood. Kendig's Disorders of the Respiratory Tract in Children 2006, 1107-1117. WB Saunders Company, Philadelphia. V. Chernick, T.F. Boat (Eds.).
7. Nauseef W.M. Biological roles for the NOX family NADPH oxidases. J. Biol. Chem. 2008, 283:16961-16965.
8. 2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J. Biol. Chem. 1990, 265:924-930. corrections: J. Biol. Chem. 265 (1990) 19370-19371.
9. Clark R.A., Volpp B.D., Leidal K.G., Nauseef W.M. Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J. Clin. Invest. 1990, 85:714-721.
10. Quinn M.T., Evans T., Loetterle L.R., Jesaitis A.J., Bokoch G.M. Translocation of Rac correlates with NADPH oxidase activation: evidence for equimolar translocation of oxidase components. J. Biol. Chem. 1993, 268:20983-20987.
11. Rhee S.G., Kang S.W., Chang T.S., Jeong W., Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 2001, 52:35-41.
12. 2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J. Biol. Chem. 2002, 277:45181-45187.
13. Ambruso D.R., Knall C., Abell A.N., Panepinto J., Kurkchubasche A., Thurman G., Gonzalez-Aller C., Hiester A., de Boer M., Harbeck R.J., Oyer R., Johnson G.L., Roos D. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc. Natl. Acad. Sci. USA 2000, 97:4654-4659.
14. Leavey P.J., Sellins K.S., Thurman G., Elzi D., Hiester A., Silliman C.C., Zerbe G., Cohen J.J., Ambruso D.R. In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood 1998, 92:4366-4374.
15. Rosenthal J., Thurman G.W., Cusack N., Peterson V.M., Malech H.L., Ambruso D.R. Neutrophils from patients after burn injury express a deficiency of the oxidase components p47-phox and p67-phox. Blood 1996, 88:4321-4329.
16. de Mendez I., Adams A.G., Sokolic R.A., Malech H.L., Leto T.L. Multiple SH3 domain interactions regulate NADPH oxidase assembly in whole cells. EMBO J. 1996, 15:1211-1220.
17. Leto T.L., Lavigne M.C., Homoyounpour N., Lekstrom K., Linton G., Malech H.L., de Mendez I. The K-562 cell model for analysis of neutrophil NADPH oxidase function. Meth. Mol. Biol. 2007, 412:365-383.
18. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989, 77:51-59.
19. Kang S.W., Baines I.C., Rhee S.G. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 1998, 273:6303-6311.
20. Choi H.J., Kang S.W., Yang C.H., Rhee S.G., Ryu S.E. Crystal structure of a novel human peroxidase enzyme at 2.0A resolution. Nat. Struct. Biol. 1998, 5:400-406.
21. Chen J.W., Dodia C., Feinstein S.I., Jain M.K., Fisher A.B. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J. Biol. Chem. 2000, 275:28421-28427.
22. Fujii T., Fujii J., Taniguchi N. Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur. J. Biochem. 2001, 268:218-224.
23. 2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
24. 2 structure/function, mechanism and signaling. J. Lipid Res. 2009, 50:S237-S242.
25. Manevich Y., Reddy K.S., Shuvaeva T., Feinstein S.I., Fisher A.B. Structure and phospholipase function of peroxiredoxin 6: identification of the catalytic triad and its role in phospholipid substrate binding. J. Lipid Res. 2007, 48:2306-2318.
26. Goucher D.R., Wincovitch S.M., Garfield S.H., Carbone K.M., Malik T.H. A quantitative determination of multi-protein interactions by the analysis of confocal images using a pixel-by-pixel assessment algorithm. Bioinformatics 2005, 21:3248-3254.
27. de Mendez I., Leto T.L. Functional reconstitution of the phagocyte NADPH oxidase by transfection of its multiple components in a heterologous system. Blood 1995, 85:1104-1110.
28. Sharp P.A. RNA interference-2001. Genes Dev. 2001, 15:485-490.
29. Hannon G.J. RNA interference. Nature 2002, 418:244-251.
30. Paddison P.J., Caudy A.A., Hannon G.J. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1443-1448.
31. Tuschl T., Zamore P.D., Lehmann R., Bartel B.P., Sharp P.A. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 1999, 13:3191-3197.
32. Elbashir S.M., Harboth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
33. Price M.O., McPhailJ L.C., Lambeth D., Han C.H., Knaus U.G., Dinauer M.C. Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system. Blood 2002, 99:2653-2661.
34. 2+-independent PLA2 and its organ distribution. Am. J. Physiol. 1998, 274:L750-L761.
35. Ambruso D.R., Cusack N., Thurman G. NADPH oxidase activity of neutrophil specific granules: requirements for cytosolic components and evidence of assembly during cell activation. Mol. Genet. Metab. 2004, 81:313-321.
36. Rotrosen D., Leto T.L. Phosphorylation of neutrophil 47-kDa cytosolic oxidase factor. Translocation to the membrane is associated with distinct phosphorylation events. J. Biol. Chem. 1990, 265:19910-19915.
37. Park J.W., Ma M., Ruedi J.M., Smith R.M., Babior B.M. The cytosolic components of the respiratory burst oxidase exist as a M(r) approximately 240,000 complex that acquires a membrane-binding site during activation of the oxidase in a cell-free system. J. Biol. Chem. 1992, 267:17327-17332.
38. phox. Structural basis for interactions of the Rac1 effector region and insert region with components of the respiratory burst oxidase. J. Biol. Chem. 1997, 272:18834-18841.
39. Curnutte J.T. Activation of human neutrophil nicotinamide adenine dinucleotide phosphate reduced oxidase by arachidonic acid in a cell-free system. J. Clin. Invest. 1985, 75:1740-1743.
40. McPhail L.C., Shirley P.S., Clayton C.C., Snyderman R. Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor. J. Clin. Invest. 1985, 75:1735-1739.
41. 2-induced oxidative stress. J. Cell. Biochem. 2008, 104:1274-1285.
42. 2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J. Biol. Chem. 2008, 283:33563-33568.
43. Schremmer B., Manevich Y., Feinstein S.I., Fisher A.B. Peroxiredoxins in the lung with emphasis on peroxiredoxin VI. Subcell. Biochem. 2007, 44:317-344.
44. Chatterjee S., Feinstein S.I., Dodia C., Sorokina E., Lien Y.C., Nguyen S., Debolt K., Speicher D., Fisher A.B. Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages. J. Biol. Chem. 2011, 286:11696-11706.
45. Ellison M., Thurman G., Ambruso D.R. Neutrophil p29 peroxiredoxin VI (Prdx VI) enhance bactericidal activity and chemotaxis in myeloid cells. Blood 2009, 114:552.
46. 2 activity. Biochem. J. 2009, 419:669-679.
47. Anderson M.S., Knall C., Thurman G., Mann D., Cusack N., Johnson G.L., Ambruso D.R. CP-64131, an aminobenzazepine with cytokine-like properties, stimulates human neutrophil functions through the p38-MAPK pathway. J. Leukoc. Biol. 2004, 76:477-483.
48. El Benna J., Han J., Park J.W., Schmid E., Ulevitch R.J., Babior B.M. Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. Arch. Biochem. Biophys. 1996, 334:395-400.
49. Shmelzer Z., Haddad N., Admon E., Pessach I., Leto T.L., Eitan-Hazan Z., Hershfinkel M., Levy R. Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes. J. Cell Biol. 2003, 162:683-692.
50. Shmelzer Z., Karter M., Eisenstein M., Leto T.L., Hadad N., Ben-Menahem D., Gitler D., Banani S., Wolach B., Rotem M., Levy R. Cytosolic phospholipase A2alpha is targeted to the p47phox-PX domain of the assembled NADPH oxidase via a novel binding site in its C2 domain. J. Biol. Chem. 2010, 283:31898-31908.